RIOTECH PHARMACEUTICALS LIMITED

Company Registration Number:
04316377 (England and Wales)

Unaudited micro entity accounts for the year ended 30 November 2023

Period of accounts

Start date: 01 December 2022

End date: 30 November 2023

RIOTECH PHARMACEUTICALS LIMITED

Contents of the Financial Statements

for the Period Ended 30 November 2023

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

RIOTECH PHARMACEUTICALS LIMITED

Company Information

for the Period Ended 30 November 2023




Director: Howard Thomas
Ian Matthews
Derek John
Secretary: Linda Hugl
Registered office: 49 Arrivato Plaza,
Hall Street
St Helens
GBR
WA10 1GH
Company Registration Number: 04316377 (England and Wales)

RIOTECH PHARMACEUTICALS LIMITED

Directors' Report Period Ended 30 November 2023

The directors present their report with the financial statements of the company for the period ended 30 November 2023

Principal Activities

The company's principal activity during the year continued to be that of drug research and development.

Directors

The directors shown below have held office during the whole of the period from 01 December 2022 to 30 November 2023
Howard Thomas
Ian Matthews
Derek John

Secretary
Linda Hugl

This report was approved by the board of directors on 16 August 2024
And Signed On Behalf Of The Board By:

Name: Ian Matthews
Status: Director

RIOTECH PHARMACEUTICALS LIMITED

Profit and Loss Account

for the Period Ended 30 November 2023


2023
£

2022
£
Turnover 0 7,056
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 0 ) ( 6,904 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 0 ) ( 152 )
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period 0 0

RIOTECH PHARMACEUTICALS LIMITED

Balance sheet

As at 30 November 2023


2023
£

2022
£
Called up share capital not paid: 0 0
Fixed Assets: 0 0
Current assets: 1,695 1,695
Prepayments and accrued income: 184 184
Creditors: amounts falling due within one year: ( 0 ) ( 0 )
Net current assets (liabilities): 1,879 1,879
Total assets less current liabilities: 1,879 1,879
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 1,879 1,879
Capital and reserves: 1,879 1,879

RIOTECH PHARMACEUTICALS LIMITED

Balance sheet continued

For the year ending 30 November 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 16 August 2024
And Signed On Behalf Of The Board By:

Name: Ian Matthews
Status: Director

The notes form part of these financial statements

RIOTECH PHARMACEUTICALS LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 November 2023

  • 1. Employee Information

    Average number of employees: 0

RIOTECH PHARMACEUTICALS LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 November 2023

  • 2. Off balance sheet disclosure

    No